A Study to Learn About Medicine Called Ritlecitinib in Children Aged Between 6 to 12 Years With Severe Alopecia Areata

NCT07029711 · clinicaltrials.gov ↗

PHASE3

Phase

RECRUITING

Status

225

Enrollment

INDUSTRY

Sponsor class

Conditions

Severe Alopecia Areata

Interventions

DRUG: Ritlecitinib higher dose
DRUG: Ritlecitinib lower dose
DRUG: Placebo

Sponsor

Pfizer